Skip to main content

Table 1 Patient demographics and IV iron treatment characteristics at baseline

From: A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

 

Total population(n = 198)

Patient demographics

Gender, n (%)

 Female

67 (33.8)

 Male

131 (66.2)

Age (years)

 Mean (SD)

70.3 (13.0)

Weight (kg)

 Mean (SD)

78.2 (19.7)

IV iron treatment characteristics at baseline

Time between last IS treatment and start of IIM prospective study phasea (months)

 Mean (SD)

3.8 (2.4)

Patients with previous IIM treatment,b n (%)

166 (83.8)

  1. aStart of IIM prospective study phase determined by the date of informed consent. bIIM treatment after the last IS treatment and before start of the IIM prospective study phase
  2. IIM iron isomaltoside, IS iron sucrose, IV intravenous, n number of patients, SD standard deviation